Sibilla diario 2 mg / 0 clinical trials

CARESS Study: Cabergoline for the Reduction of Endometriosis Symptoms and Lesion Size

This study, called CARESS, is looking at how a medicine called cabergoline might help people with endometriosis. Researchers want to see if it can shrink endometriosis growths and reduce pelvic pain. It's in the later stages of testing to make sure it's safe and effective.